Overview

Drug-Induced Sleep Endoscopy for Upper Airway Evaluation in Obstructive Sleep Apnea

Status:
Recruiting
Trial end date:
2030-06-01
Target enrollment:
0
Participant gender:
All
Summary
Prospective, interventional cohort study of drug-induced sleep endoscopy (DISE) to evaluate the upper airway in a cohort of obstructive sleep apnea (OSA) surgical patients. This study has investigated the reliability of this technique, demonstrating moderate-substantial interrater and test-retest reliability. This research has also compared DISE findings to those of the lateral cephalogram X-ray and examined DISE findings in individuals who have not responded to previous sleep apnea surgery. These papers have been published and available through PubMed. Additional research is ongoing, with examination of DISE findings, comparison to other evaluation techniques, and the association between DISE findings and surgical outcomes.
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
University of Southern California
Collaborators:
American Academy of Otolaryngology-Head and Neck Surgery Foundation
National Institutes of Health (NIH)
Treatments:
Propofol
Criteria
Inclusion Criteria:

- Adult patients with OSA considering surgical treatment

Exclusion Criteria:

- Minors

- Pregnant women

- Patients unable to provide informed consent in English themselves

- Prisoners

- Allergy to propofol, soybean oil, egg lecithin or glycerol

- Other contraindication to use of propofol (decision of anesthesiologist or
otolaryngologist.)